Document Detail

Microvascular dysfunction: An emerging pathway in the pathogenesis of obesity-related insulin resistance.
MedLine Citation:
PMID:  23299657     Owner:  NLM     Status:  Publisher    
The prevalence of type 2 diabetes mellitus (T2DM) and its major risk factor, obesity, has reached epidemic proportions in Western society. How obesity leads to insulin resistance and subsequent T2DM is incompletely understood. It has been established that insulin can redirect blood flow in skeletal muscle from non-nutritive to nutritive capillary networks, without increasing total blood flow. This results in a net increase of the overall number of perfused nutritive capillary networks and thereby increases insulin-mediated glucose uptake by skeletal muscle. This process, referred to as functional (nutritive) capillary recruitment, has been shown to be endothelium-dependent and to require activation of the phosphatidylinositol-kinase (PI3K) pathway in the endothelial cell. Several studies have demonstrated that these processes are impaired in states of microvascular dysfunction. In obesity, changes in several adipokines are likely candidates to influence insulin signaling pathways in endothelial cells, thereby causing microvascular dysfunction. Microvascular dysfunction, in turn, impairs the timely access of glucose and insulin to their target tissues, and may therefore be an additional cause of insulin resistance. Thus, microvascular dysfunction may be a key feature in the development of obesity-related insulin resistance. In the present review, we will discuss the evidence for this emerging role for the microcirculation as a possible link between obesity and insulin resistance.
Dennis M J Muris; Alfons J H M Houben; Miranda T Schram; Coen D A Stehouwer
Related Documents :
23786297 - Delivering on george eisenbarth's visionary pursuit of understanding pathogenesis and p...
23776897 - Future of newer basal insulin.
17288097 - Noninvasive approach to diabetes screening and monitoring shows promise.
24299427 - Impact of roux-en-y gastric bypass on metabolic syndrome and insulin resistance paramet...
17651487 - 'correction:' serum transforming growth factor beta-1 (tgf-beta-1) levels in diabetic p...
9626977 - Catabolite repressors are potent antimutagens in escherichia coli plate incorporation a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-9
Journal Detail:
Title:  Reviews in endocrine & metabolic disorders     Volume:  -     ISSN:  1573-2606     ISO Abbreviation:  Rev Endocr Metab Disord     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100940588     Medline TA:  Rev Endocr Metab Disord     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluating the Most Effective Distribution Strategies to Assure Administration of Pandemic H1N1 Infl...
Next Document:  Type 2 diabetes mellitus and exercise impairment.